Novo Nordisk

Novo Nordisk is a global leader within diabetes and obesity research and is the highest valued company in the Nordics.

Working with a client such as Novo Nordisk with the purpose of “Driving change to defeat diabetes and other serious chronic diseases” really makes our work worthwhile and motivating. In May we produced the CSS, Commercial Strategy Summit, assembling some 250 global managers in Copenhagen. Taking part of the professionalism and high ambition throughout the project, with stakeholders, speakers and the core project team was a really inspiring experience.

The CSS focused on how to bring the unique treatments available in Novo Nordisk´s portfolio to the patients globally which is a dire challenge.